Volume 143, Issue 2, Pages e1 (August 2012)

Slides:



Advertisements
Similar presentations
Oxidized Low-Density Lipoprotein Is a Novel Predictor of Interferon Responsiveness in Chronic Hepatitis C Infection  Philipp Solbach, Sandra Westhaus,
Advertisements

Volume 16, Issue 3, Pages (March 2008)
Volume 138, Issue 3, Pages (March 2010)
Volume 148, Issue 2, Pages e7 (February 2015)
Volume 136, Issue 1, Pages e2 (January 2009)
Volume 135, Issue 5, Pages e1 (November 2008)
Volume 129, Issue 3, Pages (September 2005)
Volume 143, Issue 2, Pages e8 (August 2012)
Volume 141, Issue 2, Pages e3 (August 2011)
Replication of Hepatitis C Virus Genotype 3a in Cultured Cells
HIV Increases HCV Replication in a TGF-β1–Dependent Manner
Volume 140, Issue 2, Pages (February 2011)
Volume 142, Issue 7, Pages e6 (June 2012)
Volume 133, Issue 4, Pages (October 2007)
Volume 145, Issue 6, Pages e1 (December 2013)
Volume 132, Issue 4, Pages (April 2007)
Volume 128, Issue 1, Pages (January 2005)
Hepatitis C Virus Infection of Neuroepithelioma Cell Lines
Volume 141, Issue 3, Pages (September 2011)
Volume 128, Issue 4, Pages (April 2005)
Volume 146, Issue 3, Pages e4 (March 2014)
Volume 143, Issue 1, Pages e5 (July 2012)
Volume 145, Issue 5, Pages e7 (November 2013)
Volume 150, Issue 1, Pages e4 (January 2016)
Volume 124, Issue 7, Pages (June 2003)
Volume 148, Issue 2, Pages e7 (February 2015)
Zinc Mesoporphyrin Induces Rapid Proteasomal Degradation of Hepatitis C Nonstructural 5A Protein in Human Hepatoma Cells  Weihong Hou, Qing Tian, Jianyu.
Recruitment of Ataxia-Telangiectasia Mutated to the p21waf1 Promoter by ZBP-89 Plays a Role in Mucosal Protection  Longchuan Bai, John Y. Kao, David J.
Volume 144, Issue 1, Pages e6 (January 2013)
Volume 139, Issue 1, Pages (July 2010)
Volume 135, Issue 5, Pages e3 (November 2008)
Volume 11, Issue 6, Pages (June 2012)
Sp1 Is Required for Glucose-Induced Transcriptional Regulation of Mouse Vesicular Glutamate Transporter 2 Gene  Tao Li, Liqun Bai, Jing Li, Suzu Igarashi,
Volume 137, Issue 5, Pages (November 2009)
Volume 133, Issue 5, Pages (November 2007)
Volume 17, Issue 5, Pages (October 2016)
Volume 136, Issue 4, Pages (April 2009)
Volume 143, Issue 2, Pages e8 (August 2012)
Volume 138, Issue 5, Pages e2 (May 2010)
Volume 140, Issue 4, Pages e1 (April 2011)
Volume 135, Issue 5, Pages e2 (November 2008)
Volume 44, Issue 2, Pages (February 2006)
Volume 140, Issue 3, Pages (March 2011)
Volume 145, Issue 5, Pages e7 (November 2013)
Volume 18, Issue 11, Pages (November 2011)
Volume 132, Issue 4, Pages (April 2007)
Glucocorticosteroids Increase Cell Entry by Hepatitis C Virus
Volume 135, Issue 3, Pages e3 (September 2008)
Volume 131, Issue 6, Pages (December 2006)
Volume 145, Issue 3, Pages e11 (September 2013)
Volume 138, Issue 3, Pages (March 2010)
Volume 5, Issue 3, Pages (March 2009)
1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression  Yingjian Li, Bradley C.
Volume 132, Issue 5, Pages (May 2007)
Volume 133, Issue 4, Pages (October 2007)
Volume 137, Issue 2, Pages (August 2009)
Incorporation of the B18R Gene of Vaccinia Virus Into an Oncolytic Herpes Simplex Virus Improves Antitumor Activity  Xinping Fu, Armando Rivera, Lihua.
Volume 138, Issue 7, Pages e1 (June 2010)
Gang Wang, Na Zhao, Ben Berkhout, Atze T Das  Molecular Therapy 
Volume 150, Issue 1, Pages e4 (January 2016)
Volume 126, Issue 7, Pages (June 2004)
Volume 128, Issue 3, Pages (March 2005)
The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration  Y. Rebecca Chin, Alex Toker  Molecular.
Urtzi Garaigorta, Francis V. Chisari  Cell Host & Microbe 
Md Nasimuzzaman, Danielle Lynn, Johannes CM van der Loo, Punam Malik 
MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway
Volume 22, Issue 2, Pages (February 2014)
Volume 131, Issue 5, Pages (November 2006)
by Brett D. Anderson, and Reuben S. Harris
Volume 157, Issue 3, Pages e9 (September 2019)
Presentation transcript:

Volume 143, Issue 2, Pages 439-447.e1 (August 2012) Hepatocytes That Express Variants of Cyclophilin A Are Resistant to HCV Infection and Replication  Thomas von Hahn, Cordelia Schiene–Fischer, Nguyen Dinh Van, Stephanie Pfaender, Behya Karavul, Eike Steinmann, Andrej Potthoff, Christian Strassburg, Nabila Hamdi, Ahmed I. Abdelaziz, Christoph Sarrazin, Tobias Müller, Thomas Berg, Eric Trépo, Heiner Wedemeyer, Michael P. Manns, Thomas Pietschmann, Sandra Ciesek  Gastroenterology  Volume 143, Issue 2, Pages 439-447.e1 (August 2012) DOI: 10.1053/j.gastro.2012.04.053 Copyright © 2012 AGA Institute Terms and Conditions

Figure 1 Characterization of a novel Huh-7.5 CypAlow cell line. (A) Immunoblot for human CypA and β-actin in Huh-7.5 cells expressing an irrelevant or CypA-specific shRNA (Huh-7.5/CypAlow). (B) Parental Huh-7.5 cells, Huh-7.5 cells expressing an shRNA against CypA (Huh-7.5/CypAlow), and Huh-7.5/CypAlow cells transduced to express an shRNA-resistant CypA wild-type transgene were transfected with a luciferase reporter virus genome (F-luc Jc1) and seeded into replicated tissue culture plates. HCV RNA replication was quantified by measuring luciferase activity after 4, 24, 48, and 72 hours. Mean values and the SD of 3 independent experiments are shown. Gastroenterology 2012 143, 439-447.e1DOI: (10.1053/j.gastro.2012.04.053) Copyright © 2012 AGA Institute Terms and Conditions

Figure 2 Effect of different PPIA SNPs on the HCV life cycle. (A) Parental Huh-7.5 cells, Huh-7.5/CypAlow cells, and Huh-7.5/CypAlow cells expressing human CypA variants were inoculated with supernatant containing F-luc Jc1 reporter virus. Luciferase activity was assayed 48 hours after infection. Mean values and the SD of 3 independent experiments are shown. P < .05. (B) Lentiviral HCV pseudoparticles with strain H77 (genotype 1a) glycoproteins were used to infect Huh-7.5 shCypA expressing different CypA SNPs. Pseudoparticles with the glycoprotein of the vesicular stomatitis virus (VSV-G) served as positive controls; pseudoparticles without viral glycoproteins obtained after transfection of an empty vector (pcDNA) in lieu of a vector encoding a viral glycoprotein were used to define the background of the assay. A representative of 3 independent experiments is shown. Mean values of quadruplicate measurement and the SD are given. (C and D) Huh-7.5/CypAlow cells expressing different CypA variants were electroporated with (C) F-luc Jc1 RNA transcripts or (D) F-luc JFH1 subgenomic RNA transcripts, and luciferase activity over the following 72 hours was monitored as indicated. (E) To assess the efficiency of viral particle production, the different cells were transfected with Jc1 wild-type RNA transcripts and after 48 hours intracellular and extracellular core was measured by a core enzyme-linked immunosorbent assay. (F) Huh-7.5/CypAlow cells expressing the CypA variant N106I or parental Huh-7.5 cells were transduced either with CypA wild-type or CypA N106I, respectively, at decreasing dilutions. After 48 hours, cells were inoculated with supernatant containing F-luc Jc1 reporter virus. Luciferase activity was assayed 48 hours after infection. *P < .05. Gastroenterology 2012 143, 439-447.e1DOI: (10.1053/j.gastro.2012.04.053) Copyright © 2012 AGA Institute Terms and Conditions

Figure 3 Effects of PPIA SNPs on different HCV genotypes. Huh-7.5/CypAlow cells expressing the different CypA variants were inoculated with chimeric viruses consisting of the structural region and NS2 from genotypes 1a, 1b, 3a, 4a, and 5a and NS3-5B from the genotype 2a isolate JFH-1. HCV replication was assessed in a 50% tissue culture infective dose assay. Cells were fixed and stained for NS5A expression 48 hours after inoculation, and 50% tissue culture infective dose per milliliter was determined. Gastroenterology 2012 143, 439-447.e1DOI: (10.1053/j.gastro.2012.04.053) Copyright © 2012 AGA Institute Terms and Conditions

Figure 4 Alisporivir retains its antiviral activity in the presence of CypA variants. (A and B) Huh-7.5/CypAlow cells expressing CypA variants were transfected with a luciferase reporter virus genome (F-luc Jc1) and increasing doses of alisporivir were added to the medium 4 hours after transfection. At 48 hours after transfection, HCV replication was measured by luciferase activity. A representative of 3 independent experiments is shown. Gastroenterology 2012 143, 439-447.e1DOI: (10.1053/j.gastro.2012.04.053) Copyright © 2012 AGA Institute Terms and Conditions

Figure 5 SNPs associated with an HCV refractory phenotype lead destabilize CypA. (A) PPIA messenger RNA in Huh-7.5 or Huh-7.5/CypAlow cells expressing CypA variants was measured by quantitative reverse-transcriptase polymerase chain reaction using oligonucleotides binding within the CypA open reading frame. (B) CypA protein expression in Huh-7.5/CypAlow cells expressing CypA variants was detected by immunoblotting with a monoclonal antibody against CypA. β-actin served as a loading control. (C) Sodium dodecyl sulfate/polyacrylamide gel electrophoresis analysis of cell lysate of E coli M15 cells overexpressing wild-type CypA or CypA variants R55A, D66E, N106I, or G96D, respectively, induced by 1 mmol/L isopropyl β-D-1-thiogalactopyranoside before and after bacterial cell disruption using a French press. Samples were loaded on 15% sodium dodecyl sulfate/polyacrylamide gel electrophoresis using sodium dodecyl sulfate sample loading buffer. (D) Detection of CypA over time by immunoblotting in cells treated with the translation inhibitor cycloheximide (100 μg/mL). β-actin served as a loading control. Untreated naïve Huh-7.5 cells served as an internal control. (E) Thermal unfolding of 10 μmol/L CypA wild-type or CypA D66E was observed by circular dichroism, measuring ellipticity at 222 nm from 30°C to 80°C in 10 mmol/L sodium phosphate buffer, pH 7.5. The transition midpoints of CypA wild-type or CypA D66E are 52.7 ± 0.2°C and 47.2 ± 0.1°C, respectively. Gastroenterology 2012 143, 439-447.e1DOI: (10.1053/j.gastro.2012.04.053) Copyright © 2012 AGA Institute Terms and Conditions

Figure 6 Effect of proteasome inhibition on the stability of CypA N106I. Huh-7.5/CypAlow cells expressing the CypA N106I variant were treated with the proteasome inhibitor atazanavir at different concentrations for 6 hours. Then cells were lysed and CypA expression was detected by immunoblotting. Untreated Huh-7.5/CypAlow cells expressing wild-type CypA served as controls. Gastroenterology 2012 143, 439-447.e1DOI: (10.1053/j.gastro.2012.04.053) Copyright © 2012 AGA Institute Terms and Conditions

Supplementary Figure 1 Nonsynonymous SNPs in PPIA. (A) Schematic representation of PPIA with the position of 6 amino acid changes caused by known nonsynonymous SNPs in the coding region (exon 4 and 5). Boxes indicate exons, with gray and black portions indicating the untranslated regions and the open reading frame, respectively. (B) The structure of human cyclophilin A (PDB entry 1RMH) in complex with a tetrapeptide substrate with the positions of the SNP mutations highlighted. Amino acid side chains are shown in stick representation in green, and the tetrapeptide substrate Suc-AAPF-pNa is depicted in blue. (Left) Side view; (right) front view. Gastroenterology 2012 143, 439-447.e1DOI: (10.1053/j.gastro.2012.04.053) Copyright © 2012 AGA Institute Terms and Conditions

Supplementary Figure 2 Flow cytometric analysis of GFP expression in Huh-7.5/CypAlow cells transduced to express CypA variants using an expression vector (pWPI-GUN) that also encodes a GFP-neomycin-resistance fusion protein from a separate cistron. Measurements were performed at the time when susceptibility to HCVcc was assessed. Gastroenterology 2012 143, 439-447.e1DOI: (10.1053/j.gastro.2012.04.053) Copyright © 2012 AGA Institute Terms and Conditions